NCT02992704View on ClinicalTrials.gov

Peg-interferon for Inactive Chronic Hepatitis B Carriers

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Chronic Hepatitis, B VirusCarrier of Viral Hepatitis Type B
Interventions
DRUG

Peginterferon Alfa-2A

peginterferon alpha 2a 180mcg weekly for either 24 or 48 weeks

Trial Locations (1)

119228

National University Hospital, Singapore

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Seng Gee Lim

OTHER

NCT02992704 - Peg-interferon for Inactive Chronic Hepatitis B Carriers | Biotech Hunter | Biotech Hunter